Deleting Malignant B Cells With Second-Generation Anti-CD20 Antibodies

J Clin Oncol. 2018 Aug 1;36(22):2323-2325. doi: 10.1200/JCO.2018.78.7390. Epub 2018 Jun 12.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • B-Lymphocytes
  • Bendamustine Hydrochloride
  • Humans
  • Lymphoma, Non-Hodgkin*
  • Rituximab

Substances

  • Antibodies, Monoclonal, Humanized
  • Rituximab
  • Bendamustine Hydrochloride
  • obinutuzumab